{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005192,73,MONDO:0005192,165,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005192","source":"MONDO:0005192|exocrine pancreatic carcinoma","targets":["NCT00280709|Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction|COMPLETED|PHASE4|INTERVENTIONAL","NCT00365508|Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00558155|The Impact of Immunostimulating Nutrition on the Outcome of Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT00576940|Standard and Immunostimulating Enteral Nutrition in Surgical Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00578279|Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00583479|Prospective Study of Celiac Block Injection: 1 vs. 2|COMPLETED|PHASE4|INTERVENTIONAL","NCT00642733|A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer|TERMINATED|PHASE4|INTERVENTIONAL","NCT00666978|Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00920023|Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00966277|Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01041612|Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi|COMPLETED|PHASE4|INTERVENTIONAL","NCT01111591|Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01256034|Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01642875|Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01768988|Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study|TERMINATED|PHASE4|INTERVENTIONAL","NCT02027311|Etomidate vs. Midazolam for Sedation During ERCP|COMPLETED|PHASE4|INTERVENTIONAL","NCT02044224|Effects of Dexmedetomidine During IRE Procedures for Solid Tumours|COMPLETED|PHASE4|INTERVENTIONAL","NCT03642093|HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03891979|Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT04025840|Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04058236|Glycocalyx Levels in Patients Undergoing Pancreatectomy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04155008|Nutrition and Pharmacological Algorithm for Oncology Patients Study|TERMINATED|PHASE4|INTERVENTIONAL","NCT04217096|Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \\ Advanced Pancreatic Cancer Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04269369|Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04809935|EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05035147|Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer|RECRUITING|PHASE4|INTERVENTIONAL","NCT05245877|Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery|RECRUITING|PHASE4|INTERVENTIONAL","NCT05784311|Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)|RECRUITING|PHASE4|INTERVENTIONAL","NCT06316908|Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach|COMPLETED|PHASE4|INTERVENTIONAL","NCT06779318|Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT00003029|Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003049|Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003216|Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT00005869|Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00005870|Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00005871|Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00014651|Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection|TERMINATED|PHASE3|INTERVENTIONAL","NCT00023972|Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00024427|Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00026338|Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00030732|Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00031837|Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00032175|Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00033735|Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00040092|A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00040183|OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00044031|Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00051467|A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00057876|Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00058149|Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00058201|Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00064207|Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00075452|Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00075686|S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00088660|PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00088894|Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00099294|Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00112658|Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00113256|Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00192712|Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00268411|Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00303758|Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00387348|Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00416507|Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00425360|Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00440167|Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00486460|Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00498225|Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00541021|Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00634725|Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00644618|Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00662688|Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00679913|Standardization of Surgery on the Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00785421|Chemotherapy With or Without Enoxaparin in Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00789633|Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00806611|Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00809081|Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00813696|Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00844649|Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT00960284|Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00994110|Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess|COMPLETED|PHASE3|INTERVENTIONAL","NCT01065870|Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01072981|Immunotherapy Study for Surgically Resected Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01214720|A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01231347|QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT01314027|Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT01330823|L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)|SUSPENDED|PHASE3|INTERVENTIONAL","NCT01362582|Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT01438476|Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas|COMPLETED|PHASE3|INTERVENTIONAL","NCT01458717|Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01494506|Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01521702|NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01586611|A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01598584|Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer|WITHDRAWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01655641|Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01827553|Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT01836432|Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT01900327|Neoadjuvant Treatment in Resectable Pancreatic Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT01926197|Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01931449|Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy|UNKNOWN|PHASE3|INTERVENTIONAL"]}]}